Alberto Inga

Department CIBIO, University of Trento

Research Area

Biography

Alberto Inga has not added Biography.
If you are Alberto Inga and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 16	2019

Other Publications

Article	Year
Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation. Molecular cancer research : MCR\| PubMed ID: 20407015	2010
The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound. PloS one\| PubMed ID: 20422012	2010
Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes. Molecular cancer research : MCR\| PubMed ID: 21343334	2011
3-Methyl-3-deazaadenine, a stable isostere of N3-methyl-adenine, is efficiently bypassed by replication in vivo and by transcription in vitro. DNA repair\| PubMed ID: 21676659	2011
Contribution of yeast and plant research for improving human health. Journal of biomedicine & biotechnology\| PubMed ID: 22851885	2012
The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis. Nucleic acids research\| PubMed ID: 23161690	2013
Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics. Cell cycle (Georgetown, Tex.)\| PubMed ID: 23518503	2013
P53 family members modulate the expression of PRODH, but not PRODH2, via intronic p53 response elements. PloS one\| PubMed ID: 23861960	2013
Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code. Nucleic acids research\| PubMed ID: 23892287	2013
Comparison of the biological effects of MMS and Me-lex, a minor groove methylating agent: clarifying the role of N3-methyladenine. Mutation research\| PubMed ID: 24211855	2014
Identification of new p53 target microRNAs by bioinformatics and functional analysis. BMC cancer\| PubMed ID: 24256616	2013
A cross-platform comparison of affymetrix and Agilent microarrays reveals discordant miRNA expression in lung tumors of c-Raf transgenic mice. PloS one\| PubMed ID: 24265725	2013
Transcriptional defect of an inherited NKX2-5 haplotype comprising a SNP, a nonsynonymous and a synonymous mutation, associated with human congenital heart disease. PloS one\| PubMed ID: 24376681	2013
TP53 mutants in the tower of babel of cancer progression. Human mutation\| PubMed ID: 24449472	2014
∆N-P63α and TA-P63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites. Oncotarget\| PubMed ID: 24926492	2014
Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53-MDM2 interaction. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences\| PubMed ID: 25312347	2015
Cooperative interactions between p53 and NFκB enhance cell plasticity. Oncotarget\| PubMed ID: 25401416	2014
Evolution of p53 transactivation specificity through the lens of a yeast-based functional assay. PloS one\| PubMed ID: 25668429	2015
In-silico identification and functional validation of allele-dependent AR enhancers. Oncotarget\| PubMed ID: 25693204	2015
Whole-genome cartography of p53 response elements ranked on transactivation potential. BMC genomics\| PubMed ID: 26081755	2015
Quantitative Analysis of NF-κB Transactivation Specificity Using a Yeast-Based Functional Assay. PloS one\| PubMed ID: 26147604	2015
RiboAbacus: a model trained on polyribosome images predicts ribosome density and translational efficiency from mammalian transcriptomes. Nucleic acids research\| PubMed ID: 26240374	2015
Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas. Oncotarget\| PubMed ID: 26427040	2015
Enhanced cytotoxicity of prenylated chalcone against tumour cells via disruption of the p53-MDM2 interaction. Life sciences\| PubMed ID: 26475964	2015
The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding. Oncotarget\| PubMed ID: 26498684	2015
The CDKN2A/p16(INK) (4a) 5'UTR sequence and translational regulation: impact of novel variants predisposing to melanoma. Pigment cell & melanoma research\| PubMed ID: 26581427	2016
Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule. Oncotarget\| PubMed ID: 26735173	2016
The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer. Cancer research\| PubMed ID: 27197265	2016
c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma. Oncotarget\| PubMed ID: 27602772	2016
Human transcription factors in yeast: the fruitful examples of P53 and NF-кB. FEMS yeast research\| PubMed ID: 27683095	2016
The structure formed by inverted repeats in p53 response elements determines the transactivation activity of p53 protein. Biochemical and biophysical research communications\| PubMed ID: 28007599	2017
DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties. Molecular oncology\| PubMed ID: 28296148	2017
Inherited determinants of early recurrent somatic mutations in prostate cancer. Nature communications\| PubMed ID: 28663546	2017
Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity. Genome research\| PubMed ID: 28904012	2017
A highly specific SpCas9 variant is identified by in vivo screening in yeast. Nature biotechnology\| PubMed ID: 29431739	2018
Synthesis of 2,6-Diamino-Substituted Purine Derivatives and Evaluation of Cell Cycle Arrest in Breast and Colorectal Cancer Cells. Molecules (Basel, Switzerland)\| PubMed ID: 30103421	2018
Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in 53-deficient cancer cells. Cell division\| PubMed ID: 30603043	2018
LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-β. Nature communications\| PubMed ID: 31036808	2019